Literature DB >> 16222399

Consensus statement on dementia of Alzheimer type in the severe stage.

B Vellas, S Gauthier, H Allain, S Andrieu, J P Aquino, G Berrut, M Berthel, F Blanchard, V Camus, J F Dartigues, B Dubois, F Forette, A Franco, R Gonthier, A Grand, M P Hervy, C Jeandel, M E Joel, P Jouanny, F Lebert, P Michot, J L Montastruc, F Nourhashemi, P J Ousset, J Pariente, A S Rigaud, P Robert, G Ruault, D Strubel, J Touchon, M Verny, J M Vetel.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 16222399

Source DB:  PubMed          Journal:  J Nutr Health Aging        ISSN： 1279-7707            Impact factor:   4.075


× No keyword cloud information.
  9 in total

1.  Effectiveness and tolerability of high-dose (23 mg/d) versus standard-dose (10 mg/d) donepezil in moderate to severe Alzheimer's disease: A 24-week, randomized, double-blind study.

Authors:  Martin R Farlow; Stephen Salloway; Pierre N Tariot; Jane Yardley; Margaret L Moline; Qin Wang; Elimor Brand-Schieber; Heng Zou; Timothy Hsu; Andrew Satlin
Journal:  Clin Ther       Date:  2010-07       Impact factor: 3.393

Review 2.  Managing cognitive dysfunction through the continuum of Alzheimer's disease: role of pharmacotherapy.

Authors:  Julien Delrieu; Antoine Piau; Céline Caillaud; Thierry Voisin; Bruno Vellas
Journal:  CNS Drugs       Date:  2011-03       Impact factor: 5.749

3.  Follow-up for Alzheimer patients: European Alzheimer Disease Consortium position paper.

Authors:  F Nourhashémi; M G Olde Rikkert; A Burns; B Winblad; G B Frisoni; J Fitten; B Vellas
Journal:  J Nutr Health Aging       Date:  2010-02       Impact factor: 4.075

Review 4.  Diagnosis and treatment of patients with severe Alzheimer's disease.

Authors:  Thierry Voisin; Bruno Vellas
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

5.  A randomized trial of the impact of a specific care plan in 1120 Alzheimer's patients (PLASA Study) over a two-year period: design and baseline data.

Authors:  F Nourhashemi; S Gillette-Guyonnet; S Andrieu; Y Rolland; P-J Ousset; B Vellas
Journal:  J Nutr Health Aging       Date:  2008-04       Impact factor: 4.075

6.  Real-world characteristics of hospitalized frail elderly patients with atrial fibrillation: can we improve the current prescription of anticoagulants?

Authors:  Giorgio Annoni; Paolo Mazzola
Journal:  J Geriatr Cardiol       Date:  2016-03       Impact factor: 3.327

7.  Clinical Utility of the Cognitive Test for Severe Dementia: Factor Analysis, Minimal Detectable Change, and Longitudinal Changes.

Authors:  Hiroyuki Tanaka; Yuma Nagata; Daiki Ishimaru; Yasuhiro Ogawa; Keita Fukuhara; Takashi Nishikawa
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2018-06-07

8.  Increased plasma neurofilament light chain concentration correlates with severity of post-mortem neurofibrillary tangle pathology and neurodegeneration.

Authors:  Nicholas J Ashton; Antoine Leuzy; Yau Mun Lim; Claire Troakes; Tibor Hortobágyi; Kina Höglund; Dag Aarsland; Simon Lovestone; Michael Schöll; Kaj Blennow; Henrik Zetterberg; Abdul Hye
Journal:  Acta Neuropathol Commun       Date:  2019-01-09       Impact factor: 7.801

9.  Development of a New Daily Activities Scale for the Affected Hand after Stroke.

Authors:  Koshi Matsuoka; Aki Watanabe; Takayuki Kawaguchi; Koji Misawa; Keiichi Murakami; Michinari Fukuda
Journal:  Prog Rehabil Med       Date:  2020-12-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.